基于“脾主运化”理论改善胰岛素抵抗治疗肥胖的相关机制研究
Research on the Related Mechanisms of Improving Insulin Resistance for Treating Obesity Based on the Theory of “Spleen Governing Transportation and Transformation”
DOI: 10.12677/tcm.2026.154182, PDF,   
作者: 汪 宇:成都中医药大学临床医学院,四川 成都;龚光明*:成都中医药大学附属医院内分泌科,四川 成都
关键词: “脾主运化”胰岛素抵抗肥胖“Spleen Governing Transportation and Transformation” Insulin Resistance Obesity
摘要: 肥胖作为一种以体内脂肪过度累积为特征的慢性代谢性疾病,现有研究表明胰岛素抵抗为其发病的核心机制之一。中医认为本病可归于肥胖、脾瘅等范畴,病机为本虚标实之候,本虚在脾胃,标实在痰湿。脾虚则不能运化水谷精微,聚而成痰湿;痰湿困于中焦则进一步加重脾虚,互相因果导致肥胖;且脾运化水谷精微与胰岛素促进葡萄糖为机体提供能量高度重合,脾不散精为胰岛素抵抗的病因病机。故文章旨在从中西医理论实践双重视角,以“脾主运化”理论为基础,系统梳理近年来中医药改善胰岛素抵抗治疗肥胖的机制,并探讨肥胖的病因病机及治疗思路,以期为本病的临床诊断和治疗提供新的思路和参考。
Abstract: Obesity is a chronic metabolic disorder characterized by excessive fat accumulation in the body, with existing studies identifying insulin resistance as one of its core pathogenic mechanisms. Traditional Chinese Medicine (TCM) holds that this disease belongs to the categories of obesity, spleen dyanesthesia and other related disorders, with its pathogenesis characterized by “deficiency in root and excess in branch”—the root deficiency lies in the spleen and stomach, while the branch excess manifests as phlegm-dampness. Insufficiency of spleen function impairs its ability to transport and transform the nutrients of food and water, which then accumulate to form phlegm-dampness; in turn, phlegm-dampness stagnates in the middle jiao, further exacerbating spleen insufficiency, forming a mutual causal relationship that ultimately leads to obesity. Furthermore, the spleen’s function of transporting and transforming food nutrients is highly consistent with insulin’s role in promoting glucose metabolism to provide energy for the body, and the failure of the spleen to disperse nutrients serves as the pathogenetic basis of insulin resistance. Therefore, this study aims to systematically summarize the mechanisms by which traditional Chinese medicine improves insulin resistance in the treatment of obesity in recent years, based on the theory of “spleen governing transportation and transformation”, from the dual perspectives of TCM and modern medicine theories and practices. It also explores the etiology, pathogenesis, and treatment strategies of obesity in order to provide new insights and references for the clinical diagnosis and treatment of this disease.
文章引用:汪宇, 龚光明. 基于“脾主运化”理论改善胰岛素抵抗治疗肥胖的相关机制研究[J]. 中医学, 2026, 15(4): 64-70. https://doi.org/10.12677/tcm.2026.154182

参考文献

[1] Rubino, F., Cummings, D.E., Eckel, R.H., Cohen, R.V., Wilding, J.P.H., Brown, W.A., et al. (2025) Definition and Diagnostic Criteria of Clinical Obesity. The Lancet Diabetes & Endocrinology, 13, 221-262. [Google Scholar] [CrossRef] [PubMed]
[2] Pan, X., Wang, L. and Pan, A. (2021) Epidemiology and Determinants of Obesity in China. The Lancet Diabetes & Endocrinology, 9, 373-392. [Google Scholar] [CrossRef] [PubMed]
[3] Ježek, P., Jabůrek, M., Holendová, B. and Plecitá-Hlavatá, L. (2018) Fatty Acid-Stimulated Insulin Secretion vs. Lipotoxicity. Molecules, 23, Article 1483. [Google Scholar] [CrossRef] [PubMed]
[4] Ahmed, B., Sultana, R. and Greene, M.W. (2021) Adipose Tissue and Insulin Resistance in Obese. Biomedicine & Pharmacotherapy, 137, Article 111315. [Google Scholar] [CrossRef] [PubMed]
[5] Schenk, S., Saberi, M. and Olefsky, J.M. (2008) Insulin Sensitivity: Modulation by Nutrients and Inflammation. Journal of Clinical Investigation, 118, 2992-3002. [Google Scholar] [CrossRef] [PubMed]
[6] 国家卫生健康委员会肥胖症诊疗指南编写委员会, 张忠涛, 纪立农. 肥胖症诊疗指南(2024年版) [J]. 中国循环杂志, 2025, 40(1): 6-30.
[7] 郭霭春. 黄帝内经素问校注语译[M]. 天津: 天津科学技术出版社, 1981.
[8] 姜立娟, 李玉国, 崔巍, 等. “脾主运化”理论与胰岛素抵抗关系探微[J]. 吉林中医药, 2021, 41(2): 157-159.
[9] 晁俊, 刘桠, 钟文, 等. 基于“脾胰同源”理论从脾论治糖尿病[J]. 中医杂志, 2017, 58(17): 1458-1461.
[10] 张立志, 许能贵, 杨小林, 等. 基于“脾气散精”理论探讨从脾论治胰岛素抵抗[J]. 中国中医基础医学杂志, 2022, 28(6): 875-877.
[11] 刘芳钰, 冷锦红. 从脾论治脂肪组织参与肥胖型胰岛素抵抗[J]. 中国中医药图书情报杂志, 2024, 48(2): 20-24.
[12] 王露, 白俊, 朱虹丽, 等. 基于“脾气散精”理论探讨多囊卵巢综合征伴胰岛素抵抗[J]. 长春中医药大学学报, 2020, 36(3): 409-411.
[13] 李艳, 翁思颖. 基于虚痰浊瘀论治伴有胰岛素抵抗的肥胖症[J]. 山西中医药大学学报, 2024, 25(5): 545-549.
[14] Czech, M.P. (2020) Mechanisms of Insulin Resistance Related to White, Beige, and Brown Adipocytes. Molecular Metabolism, 34, 27-42. [Google Scholar] [CrossRef] [PubMed]
[15] Vekic, J., Zeljkovic, A., Stefanovic, A., Jelic-Ivanovic, Z. and Spasojevic-Kalimanovska, V. (2019) Obesity and Dyslipidemia. Metabolism, 92, 71-81. [Google Scholar] [CrossRef] [PubMed]
[16] Han, W., Fessel, J.P., Sherrill, T., Kocurek, E.G., Yull, F.E. and Blackwell, T.S. (2020) Enhanced Expression of Catalase in Mitochondria Modulates NF-κB-Dependent Lung Inflammation through Alteration of Metabolic Activity in Macrophages. The Journal of Immunology, 205, 1125-1134. [Google Scholar] [CrossRef] [PubMed]
[17] 马浩洋, 冯志海, 任秋月, 等. 基于NF-κB信号通路探讨中药单体改善糖尿病周围神经病变机制[J]. 陕西中医, 2024, 45(11): 1565-1569.
[18] Nguyen, M.T.A., Favelyukis, S., Nguyen, A., Reichart, D., Scott, P.A., Jenn, A., et al. (2007) A Subpopulation of Macrophages Infiltrates Hypertrophic Adipose Tissue and Is Activated by Free Fatty Acids via Toll-Like Receptors 2 and 4 and JNK-Dependent Pathways. Journal of Biological Chemistry, 282, 35279-35292. [Google Scholar] [CrossRef] [PubMed]
[19] Tilg, H., Ianiro, G., Gasbarrini, A. and Adolph, T.E. (2025) Adipokines: Masterminds of Metabolic Inflammation. Nature Reviews Immunology, 25, 250-265. [Google Scholar] [CrossRef] [PubMed]
[20] Jernås, M., Palming, J., Sjöholm, K., Jennische, E., Svensson, P., Gabrielsson, B.G., et al. (2006) Separation of Human Adipocytes by Size: Hypertrophic Fat Cells Display Distinct Gene Expression. The FASEB Journal, 20, 1540-1542. [Google Scholar] [CrossRef] [PubMed]
[21] He, J., Zhang, P., Shen, L., Niu, L., Tan, Y., Chen, L., et al. (2020) Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism. International Journal of Molecular Sciences, 21, Article 6356. [Google Scholar] [CrossRef] [PubMed]
[22] Ducastel, S., Touche, V., Trabelsi, M., Boulinguiez, A., Butruille, L., Nawrot, M., et al. (2020) The Nuclear Receptor FXR Inhibits Glucagon-Like Peptide-1 Secretion in Response to Microbiota-Derived Short-Chain Fatty Acids. Scientific Reports, 10, Article No. 174. [Google Scholar] [CrossRef] [PubMed]
[23] [金]李东垣. 脾胃论[M]. 太原: 山西科学技术出版社, 2018: 14.
[24] 李梦瑶, 于澄元, 樊薛津, 等. 健脾祛湿方对肥胖大鼠脂质代谢及慢性炎症的影响[J]. 药物评价研究, 2025, 48(9): 2433-2440.
[25] 赵子楠, 朱依琳, 郑立新, 等. 健脾利湿泄浊方对脾虚湿阻型肥胖大鼠减肥作用的研究[J]. 环球中医药, 2022, 15(12): 2297-2303.
[26] 徐文文, 王蛮蛮, 崔芬芬, 等. 健脾化湿祛痰方对单纯性肥胖儿童糖脂代谢、胰岛素抵抗及生长激素的影响[J]. 中国中医药科技, 2024, 31(4): 649-651.
[27] 喻松仁, 徐佳玲, 刘志勇, 等. 基于胰岛巨噬细胞M1极化探讨温胆汤对肥胖痰湿证炎症状态的影响[J/OL]. 中华中医药学刊, 1-20.
https://link.cnki.net/urlid/21.1546.r.20250620.1124.018, 2025-10-31.
[28] 赵娟, 叶丽芳, 梁舒, 等. 三黄汤通过抑制脂肪组织间巨噬细胞浸润及炎症因子表达改善肥胖小鼠的胰岛素抵抗[J]. 南京中医药大学学报, 2018, 34(4): 381-385.
[29] 王文炎, 刘静, 黄裳, 等. 电针通过SIRT1调节脂肪Th17/Treg细胞平衡改善胰岛素抵抗肥胖的机制研究[J]. 针刺研究, 2025, 50(9): 1013-1020.
[30] 武欢, 梁凤霞, 陈邦国, 等. 电针对胰岛素抵抗肥胖大鼠炎性反应和肠道屏障的影响[J]. 中国针灸, 2019, 39(11): 1199-1204.
[31] https://link.cnki.net/urlid/61.1526.R.20250624.0936.002
[32] 张妍, 刘志丹, 李晓燕, 等. 穴位埋线对糖调节受损伴腹型肥胖患者糖脂代谢及转归影响的临床研究[J]. 上海中医药杂志, 2019, 53(1): 62-66.
[33] 崔耀辉, 常陆春, 李彭妮, 等. 揿针疗法治疗脾虚湿阻型单纯性肥胖的效果及对血清中脂肪因子LEP、ADP、Ins水平的影响[J]. 中华中医药学刊, 2023, 41(1): 230-233.
[34] 杨东梅, 张心语, 吉章鑫, 等. 茯苓薏苡仁水提物对肥胖小鼠的影响[J]. 食品研究与开发, 2025, 46(10): 12-21.
[35] 李天海, 黄理哲, 陈慧娴. 荷叶对肥胖及代谢异常作用机制的研究进展[J]. 中国现代医生, 2025, 63(8): 110-112.
[36] 郭钦, 白洁, 何宇轩, 等. 天然产物与microRNA调控代谢综合征的研究进展[J]. 食品科学, 2017, 38(9): 239-247.
[37] 赵悦, 左军, 胡晓阳, 等. 山楂叶和山楂果的化学成分及药理作用研究进展[J]. 中医药导报, 2025, 31(8): 145-151.
[38] 刁婷婷. 山楂叶总黄酮对高血脂的调节作用[D]: [硕士学位论文]. 咸宁: 湖北科技学院, 2019.